Syndicated Reports: CRO Industry
Our syndicated reports are developed through extensive primary research with study participants screened from Life Science Strategy Group´s proprietary market research panel databases. All data analysis and reporting is performed by LSSG.
Title
Price
$575.00 USD
Preclinical R&D Trends and CRO Utilization Outlook
Published April, 2010, 47 pages
This April 2010 study examines perceptions of more than 80 decision makers within pharmaceutical and biotechnology companies in North America and Europe on trends and future outlook in preclinical R&D spending trends, program starts and stops, RFP flow, proposal characteristics, off–shoring and utilization of Contract Research Organizations (CROs) for outsourced development services.
Download Complimentary Sample Pages.
Download Now
Customers outside of the U.S.
Click here to purchase









